Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexylamine SCHEMBL8966844 | 0.83 | MMP1 (0.31) | MMP8MMP1 | |
| Cyclohexylamine SCHEMBL304798 | 0.82 | MMP8 (0.33) | MMP8MMP1MMP2 | |
| Methylamine SCHEMBL906130 | 0.76 | — | — | |
| SCHEMBL122896 | 0.76 | — | — | |
| Cyclohexylamine SCHEMBL1174422 | 0.74 | THRB (0.30) | MMP8MMP1 | |
| SCHEMBL17099908 | 0.74 | SHBG (0.33) | — | |
| Cyclohexylamine SCHEMBL4530522 | 0.74 | MMP8 (0.38) | MMP8MMP1MMP2 | |
| Ammonia Solution, Strong SCHEMBL28446373 | 0.73 | — | — | |
| SCHEMBL28285694 | 0.73 | — | — | |
| SCHEMBL30565014 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986584-A | Preparation method and application of special amino silicone oil emulsion | 宜昌科林硅材料有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-114685735-B | Organically modified polyaluminium sulfate alkali-free liquid accelerator, preparation method thereof and early-strength alkali-free liquid accelerator | 江苏苏博特新材料股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-114685796-B | Modified siloxane, preparation method thereof and application thereof in early-strength alkali-free liquid accelerator | 四川苏博特新材料有限公司 | 2023-09-08 | — | — | CN | claimed |
| CN-114685735-A | Organic modified polyaluminum sulfate alkali-free liquid accelerator, preparation method thereof and early-strength alkali-free liquid accelerator | 江苏苏博特新材料股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114685796-A | Modified silane, preparation method thereof and application thereof in early-strength alkali-free liquid accelerator | 四川苏博特新材料有限公司 | 2022-07-01 | — | — | CN | claimed |
| EP-3340253-A1 | UV-RESISTANT ELECTRODE ASSEMBLY | Solvay SA (BE) | 2018-06-27 | — | — | EP | claimed |
| EP-3340252-A1 | ELECTRODE ASSEMBLY | Solvay SA (BE) | 2018-06-27 | — | — | EP | claimed |
| US-5852110-A | Method for making amino functional polysiloxane emulsions | DOW CORNING CORPORATION (US) | 1998-12-22 | — | — | US | claimed |
| CN-117986584-A | Preparation method and application of special amino silicone oil emulsion | 宜昌科林硅材料有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-114685735-B | Organically modified polyaluminium sulfate alkali-free liquid accelerator, preparation method thereof and early-strength alkali-free liquid accelerator | 江苏苏博特新材料股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-114685796-B | Modified siloxane, preparation method thereof and application thereof in early-strength alkali-free liquid accelerator | 四川苏博特新材料有限公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-114685735-A | Organic modified polyaluminum sulfate alkali-free liquid accelerator, preparation method thereof and early-strength alkali-free liquid accelerator | 江苏苏博特新材料股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114685796-A | Modified silane, preparation method thereof and application thereof in early-strength alkali-free liquid accelerator | 四川苏博特新材料有限公司 | 2022-07-01 | — | — | CN | disclosed |
| EP-3340252-A1 | ELECTRODE ASSEMBLY | Solvay SA (BE) | 2018-06-27 | — | — | EP | disclosed |
| US-20030211063-A1 | Method of making silicone emulsions having low residual volatile siloxane oligomer content | WROLSON BURT MICHAEL (US) | 2003-11-13 | — | — | US | disclosed |
| US-6627698-B2 | Batch steam distillation to remove volatile siloxane oligomers from an emulsion containing polysiloxanes and volatile siloxane oligomers prepared by emulsion polymerization of said oligomers; efficiency | DOW CORNING CORPORATION | 2003-09-30 | — | — | US | disclosed |
| US-20030059393-A1 | Method of making silicone emulsions having low residual volatile siloxane oligomer content | DOW CORNING CORPORATION | 2003-03-27 | — | — | US | disclosed |
| WO-2002070112-A2 | PERVAPORATION SEPARATION OF VOLATILE SILOXANES FROM EMULSIONS | DOW CORNING CORPORATION (US) | 2002-09-12 | — | — | WO | disclosed |
| EP-1231235-A2 | Method of making silicone emulsions having low residual volatile siloxane oligomer content | DOW CORNING CORPORATION (US) | 2002-08-14 | — | — | EP | disclosed |
| US-5705589-A | Organosilane and organopolysiloxane free radical initiators and macromonomers and graft copolymers which can be prepared with them | WACKER-CHEMIE GMBH (DE) | 1998-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211063-A1 | Method of making silicone emulsions having low residual volatile siloxane oligomer content | SMURF1, SMURF2, SRM | MMP8 1106/4885MMP1 1789/4885MMP2 2046/4885 |
| US-20030059393-A1 | Method of making silicone emulsions having low residual volatile siloxane oligomer content | SMURF1, SMURF2, SRM | MMP8 1106/4885MMP1 1789/4885MMP2 2046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.